DC News Now: New company “Addimmune” to Focus Exclusively on Developing Cure for HIV

CEO Jeff Galvin joined the “DC News Now” team to talk about the launch of Addimmune, a new company tasked with building on the HIV cure program initiated by American Gene Technologies. Galvin explains how encouraging data from early clinical trials informed the decision to create Addimmune, and the advantages of having an entire company dedicated to the HIV program and its progress through clinical trials toward commercialization. Visit Addimmune’s new website here: https://www.addimmune.com/